Skip to content

'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.

'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.

A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.

A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.

Published on

Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.

Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.

Scientists have made an important step forward in treating a deadly childhood brain tumor, using T cells engineered to target a surface sugar found on the cancer cells.

Scientists have made an important step forward in treating a deadly childhood brain tumor, using T cells engineered to target a surface sugar found on the cancer cells.